• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New progress and challenge in gynecological cancer.

作者信息

Wang Danbo

机构信息

Department of Gynecology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China. (Email:

出版信息

Ann Transl Med. 2022 Jan;10(2):119. doi: 10.21037/atm-2021-45.

DOI:10.21037/atm-2021-45
PMID:35282075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8848394/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8589/8848394/a911fd52fa40/atm-10-02-119-fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8589/8848394/a911fd52fa40/atm-10-02-119-fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8589/8848394/a911fd52fa40/atm-10-02-119-fa.jpg

相似文献

1
New progress and challenge in gynecological cancer.妇科癌症的新进展与挑战
Ann Transl Med. 2022 Jan;10(2):119. doi: 10.21037/atm-2021-45.
2
Current Status and Progress in the Treatment of Lower Limb Lymphedema After Treatment of Gynecological Oncology.妇科肿瘤治疗后下肢淋巴水肿的治疗现状及进展
Lymphat Res Biol. 2022 Jun;20(3):308-314. doi: 10.1089/lrb.2021.0035. Epub 2021 Oct 25.
3
Therapy processes, progress, and outcomes for 2 therapies for gynecological cancer patients.妇科癌症患者两种治疗方法的治疗过程、进展及结果。
Psychooncology. 2017 Dec;26(12):2069-2078. doi: 10.1002/pon.4310. Epub 2016 Dec 22.
4
New Insights on Ferroptosis and Gynecological Malignancies.铁死亡与妇科恶性肿瘤的新见解
Front Mol Biosci. 2022 Jun 14;9:921298. doi: 10.3389/fmolb.2022.921298. eCollection 2022.
5
SOX9: Advances in Gynecological Malignancies.SOX9：妇科恶性肿瘤的进展
Front Oncol. 2021 Nov 22;11:768264. doi: 10.3389/fonc.2021.768264. eCollection 2021.
6
Research Progress on Structure and Anti-Gynecological Malignant Tumor of Shikonin.紫草素的结构与抗妇科恶性肿瘤研究进展
Front Chem. 2022 Jul 8;10:935894. doi: 10.3389/fchem.2022.935894. eCollection 2022.
7
Extra-Gynecological Pelvic Pathology: A Challenge in the Differential Diagnosis of the Female Pelvis.妇科以外的盆腔病理学：女性盆腔鉴别诊断中的一项挑战
Diagnostics (Basel). 2022 Jul 12;12(7):1693. doi: 10.3390/diagnostics12071693.
8
[Gynecological oncology in new millennium].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Aug;25(4):373-6.
9
The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective.COVID-19 大流行对新诊断妇科和乳腺癌发病率的影响：一家三级中心的观点。
Arch Gynecol Obstet. 2022 Apr;305(4):945-953. doi: 10.1007/s00404-021-06259-5. Epub 2021 Sep 24.
10
Novel membrane-based targets - Therapeutic potential in gynecological cancers.新型基于膜的靶标 - 在妇科癌症中的治疗潜力。
Crit Rev Oncol Hematol. 2015 Mar;93(3):293-303. doi: 10.1016/j.critrevonc.2014.10.015. Epub 2014 Nov 18.

引用本文的文献

1
miR-21 and miR-145 as Prognostic Biomarkers for Radiotherapy Responses in Cervical Cancer Patients: A Preliminary Study.miR-21 和 miR-145 作为宫颈癌患者放疗反应的预后生物标志物：一项初步研究。
Int J Mol Sci. 2024 Sep 30;25(19):10545. doi: 10.3390/ijms251910545.
2
The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients.抗精神病药物使用与妇科癌症发病风险的Meta 分析：50402 例患者的研究。
BMC Cancer. 2024 Jun 10;24(1):712. doi: 10.1186/s12885-024-12481-6.
3
Prognostic and clinicopathological impacts of Controlling Nutritional Status (CONUT) score on patients with gynecological cancer: a meta-analysis.

本文引用的文献

1
Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.2018年国际妇产科联盟（FIGO）IB1、IB2和IIA1期宫颈癌预后列线图的开发与验证：一项大型多中心研究
Ann Transl Med. 2022 Jan;10(2):121. doi: 10.21037/atm-21-6367.
2
Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer.扩散加权成像在宫颈癌患者术前评估及术后辅助治疗预测中的价值
Ann Transl Med. 2022 Jan;10(2):120. doi: 10.21037/atm-21-5319.
3
Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression.
控制营养状况（CONUT）评分对妇科癌症患者的预后和临床病理影响的荟萃分析。
Nutr J. 2023 Jul 8;22(1):33. doi: 10.1186/s12937-023-00863-8.
4
MicroRNAs as Potential Biomarkers in Gynecological Cancers.微小RNA作为妇科癌症的潜在生物标志物
Biomedicines. 2023 Jun 13;11(6):1704. doi: 10.3390/biomedicines11061704.
基于微小RNA表达建立宫颈癌预后的分子风险模型
Ann Transl Med. 2022 Jan;10(2):125. doi: 10.21037/atm-21-6451.
4
Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study.基于肿瘤学结局探讨2018年国际妇产科联盟（FIGO）宫颈癌IIIC期分期的合理性：一项队列研究
Ann Transl Med. 2022 Jan;10(2):122. doi: 10.21037/atm-21-6374.
5
Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.铁死亡相关基因可识别肿瘤免疫微环境特征以预测宫颈癌预后。
Ann Transl Med. 2022 Jan;10(2):123. doi: 10.21037/atm-21-6265.
6
Management of stage I occult uterine leiomyosarcoma: effects of morcellation, second-look surgery, and adjuvant treatments on survival.I期隐匿性子宫平滑肌肉瘤的治疗：碎瘤术、二次探查手术及辅助治疗对生存的影响。
Ann Transl Med. 2022 Jan;10(2):127. doi: 10.21037/atm-21-6424.
7
Efficacy evaluation of vaginal-assisted laparoscopic radical hysterectomy and laparoscopic radical hysterectomy for cervical cancer: a single-center retrospective case series study.阴道辅助腹腔镜根治性子宫切除术与腹腔镜根治性子宫切除术治疗宫颈癌的疗效评估：一项单中心回顾性病例系列研究
Ann Transl Med. 2022 Jan;10(2):124. doi: 10.21037/atm-21-6450.
8
Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer.卵巢癌中与预后、免疫浸润及药物敏感性分析相关的可变剪接的系统表征
Ann Transl Med. 2022 Jan;10(2):126. doi: 10.21037/atm-21-6422.